BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1079340)

  • 1. [An antibody called LATS].
    Letonturier P; Tourneur R
    Nouv Presse Med; 1975 Jan; 4(3):177-9. PubMed ID: 1079340
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of long-acting thyroid stimulator. Reflections on the 1st series of results].
    Tourneur R; Letonturier P; Sénécal P
    Minerva Med; 1974 Mar; 65(19):995-8. PubMed ID: 4406464
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
    Silverstein GE; Burke G
    Arch Intern Med; 1970 Oct; 126(4):615-20. PubMed ID: 4097002
    [No Abstract]   [Full Text] [Related]  

  • 4. [Etiology of Basedow's disease, with special reference to LATS].
    Nagata K
    Naika Hokan; 1969 Jul; 16(7):297-317. PubMed ID: 4901097
    [No Abstract]   [Full Text] [Related]  

  • 5. Demonstration of the production of the long acting thyroid stimulator (LATS) by peripheral lymphocytes cultured in vitro.
    Wall JR; Good BF; Forbes IJ; Hetzel BS
    Clin Exp Immunol; 1973 Aug; 14(4):555-61. PubMed ID: 4201115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nature of "LATS" immunoglobulin with prolonged thyreotropic action and localization of its antigen].
    Benhamou-Glynn N
    Ann Inst Pasteur (Paris); 1970 Apr; 118(4):539-46. PubMed ID: 5421296
    [No Abstract]   [Full Text] [Related]  

  • 7. LATS in Graves' disease.
    McKenzie JM; Zakarija M
    Recent Prog Horm Res; 1976; 33():29-57. PubMed ID: 198858
    [No Abstract]   [Full Text] [Related]  

  • 8. Isoelectric focusing of long-acting thyroid stimulator immunoglobulin G.
    Lonergan C; Babiarz D; Burke G
    J Clin Endocrinol Metab; 1973 Mar; 36(3):439-44. PubMed ID: 4631063
    [No Abstract]   [Full Text] [Related]  

  • 9. The long-acting thyroid stimulator.
    Munro DS
    Sci Basis Med Annu Rev; 1970; ():21-30. PubMed ID: 4920180
    [No Abstract]   [Full Text] [Related]  

  • 10. Indirect immunofluorescence and generation of cyclic-AMP investigation with Graves' patients' sera.
    Szabó J; Fórizs E; Szabó T; Leövey A
    Acta Med Hung; 1986; 43(3):275-81. PubMed ID: 3035480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Simultaneous study of LATS and antimicrosomial antibodies in untreated Basedow's disease].
    Orgiazzi J; Pousset G; Durand H
    Presse Med (1893); 1971 May; 79(25):1167-8. PubMed ID: 4933634
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific and nonspecific responses in the bioassay of long-acting thyroid stimulator (LATS).
    Chopra IJ; Solomon DH; Limberg NP
    J Clin Endocrinol Metab; 1970 Oct; 31(4):382-90. PubMed ID: 5468701
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of long-acting thyroid stimulator and of thyroid autoimmunity in the pathogenesis of euthyroid endocrine ophthalmopathy.
    Földes J; Takó J; Bános C; Gesztesi E
    Acta Med Acad Sci Hung; 1971; 28(2):171-9. PubMed ID: 5172524
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recent findings on TSH, LATS and TSI].
    Yamashita K; Kugai N
    Nihon Rinsho; 1981 Sep; 39(9):2949-53. PubMed ID: 6121923
    [No Abstract]   [Full Text] [Related]  

  • 15. [Standardization of the radiobiological method for determination of long-acting thyroid stimulator (LATS) in human serum].
    Muramoto E; Nicolau W; Ikeda E; de Assis LM; Pieroni RR
    AMB Rev Assoc Med Bras; 1972 Oct; 18(10):379-88. PubMed ID: 4539360
    [No Abstract]   [Full Text] [Related]  

  • 16. [Characterization of the long-acting thyroid stimulator. Considerations on preliminary results].
    Tourneur R; Letonturier P; Sénécal P
    MMW Munch Med Wochenschr; 1974 Mar; 116(13):677-9. PubMed ID: 4212576
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-acting thyroid stimulator and related factors.
    Kendall-Taylor P; Dirmikis SM; Munro DS
    Proc R Soc Med; 1975 Apr; 68(4):252-3. PubMed ID: 1242809
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct evidence for human thyroidal stimulation by LATS-protector.
    Shishiba Y; Shimizu T; Yoshimura S; Shizume K
    J Clin Endocrinol Metab; 1973 Mar; 36(3):517-21. PubMed ID: 4739312
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.
    Ginsberg J; von Westarp C
    CMAJ; 1986 May; 134(10):1141-7. PubMed ID: 2421862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of allotypic variation in the autoantigen for thyroid stimulating autoantibodies.
    Knight A; Adams DD
    Clin Exp Immunol; 1983 May; 52(2):317-24. PubMed ID: 6134598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.